Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis

被引：0
|
作者：
Mosche Pompsch
Neslinur Fisenkci
Peter A. Horn
Markus Kraemer
Monika Lindemann
机构：
[1] Alfried Krupp Hospital,Department of Neurology
[2] University of Duisburg-Essen,Institute for Transfusion Medicine, University Hospital Essen
[3] Medical Faculty of Heinrich-Heine-University,Department of Neurology
来源：
Neurological Research and Practice | / 3卷
关键词：
Ocrelizumab; B-cell depleted patients; SARS-CoV2 vaccination; Comirnaty®; T-cell mediated response; Lack of antibody response; Multiple sclerosis; COVID-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
    Pompsch, Mosche
    Fisenkci, Neslinur
    Horn, Peter A.
    Kraemer, Markus
    Lindemann, Monika
    NEUROLOGICAL RESEARCH AND PRACTICE, 2021, 3 (01):
  • [2] Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
    Faissner, Simon
    Heitmann, Neele
    Plaza-Sirvent, Carlos
    Trendelenburg, Paulina
    Ceylan, Ulas
    Motte, Jeremias
    Bessen, Clara
    Urlaub, Doris
    Watzl, Carsten
    Overheu, Oliver
    Reinacher-Schick, Anke
    Hellwig, Kerstin
    Pfaender, Stephanie
    Schmitz, Ingo
    Gold, Ralf
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Humoral immune response after SARS-CoV-2 vaccination in cladribine-treated multiple sclerosis patients
    Mimpen, M.
    Kreiter, D.
    Kempkens, T.
    Knippenberg, S.
    Hupperts, R.
    Gerlach, O.
    VACCINE: X, 2024, 16
  • [4] Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
    Gallo, Antonio
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    d'Ambrosio, Alessandro
    Coppola, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    NEUROLOGICAL SCIENCES, 2021, 42 (09) : 3523 - 3526
  • [5] Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
    Antonio Gallo
    Rocco Capuano
    Giovanna Donnarumma
    Alvino Bisecco
    Elena Grimaldi
    Miriana Conte
    Alessandro d’Ambrosio
    Nicola Coppola
    Massimiliano Galdiero
    Gioacchino Tedeschi
    Neurological Sciences, 2021, 42 : 3523 - 3526
  • [6] Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
    Capuano, Rocco
    Bisecco, Alvino
    Conte, Miriana
    Donnarumma, Giovanna
    Altieri, Manuela
    Grimaldi, Elena
    Franci, Gianluigi
    Chianese, Annalisa
    Galdiero, Massimiliano
    Coppola, Nicola
    Tedeschi, Gioacchino
    Gallo, Antonio
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
  • [7] Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    Katz, J. D.
    Bouley, A. J.
    Jungquist, R. M.
    Douglas, E. A.
    O'Shea, I. L.
    Lathi, E. S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [8] Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
    Guerrieri S.
    Lazzarin S.
    Zanetta C.
    Nozzolillo A.
    Filippi M.
    Moiola L.
    Journal of Neurology, 2022, 269 : 39 - 43
  • [9] Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
    Guerrieri, S.
    Lazzarin, S.
    Zanetta, C.
    Nozzolillo, A.
    Filippi, M.
    Moiola, L.
    JOURNAL OF NEUROLOGY, 2022, 269 (01) : 39 - 43
  • [10] Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
    Georgieva, Zoya G.
    Doffinger, Rainer
    Kumararatne, Dinakantha
    Coles, Alasdair J.
    McCarthy, Claire
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1126 - 1130
12345